Farmsintez ao Logo

Farmsintez ao

Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.

LIFE | MOEX

Overview

Corporate Details

ISIN(s):
RU000A0JR514
LEI:
Country:
Russian Federation
Address:
Kuzmolovskii Gorodskoi Poselok, Stantsiya Kapitolovo 134, 188663 Leningrad Oblast
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Farmsintez ao is a pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily consists of prescription medicines for hospital use, targeting therapeutic areas such as oncology, infectious diseases, women's health, nephrology, and orphan diseases. The company operates a GMP-compliant scientific and production complex, which includes a high-tech facility for API synthesis and a research center focused on fine organic synthesis for new drug development. Farmsintez also provides contract manufacturing and pharmaceutical development services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Farmsintez ao filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Farmsintez ao

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Farmsintez ao via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.